Tuula Anneli Kallunki

Tuula Anneli Kallunki

Associate Professor


Publication year:
  1. 2018
  2. Published

    Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1

    Tvingsholm, S. A., Hansen, M. B., Clemmensen, K. K. B., Brix, D. M., Rafn, B., Frankel, Lisa, Louhimo, R., Moreira, José, Hautaniemi, S., Gromova, I., Jäättelä, M. & Kallunki, Tuula Anneli, 2018, In: Oncogene. 7, 2, p. 1-15 15 p., 14.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2019
  4. Published

    How to Choose the Right Inducible Gene Expression System for Mammalian Studies?

    Kallunki, Tuula Anneli, Barisic, Marin, Jaattela, Marja & Liu, B., 2019, In: Cells. 8, 8, 16 p., 796.

    Research output: Contribution to journalReviewResearchpeer-review

  5. Published

    Molecular and Transcriptional Signatures for ErbB2-Induced Invasion

    Tvingsholm, S. A., Brix, D. M. & Kallunki, Tuula Anneli, 2019, In: Current Pharmacology Reports. 5, 1, p. 43-55 13 p.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion

    Brix, D. M., Tvingsholm, S. A., Hansen, M. B., Clemmensen, K. B., Ohman, T., Siino, V., Lambrughi, M., Hansen, K., Puustinen, P., Gromova, I., James, P., Papaleo, E., Varjosalo, M., Moreira, José, Jäättelä, M. & Kallunki, Tuula Anneli, 2019, In: Oncogene. 38, p. 3170-3184

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. 2020
  8. Published

    Seeking and Exploring Efficient Ways to Target Cancer

    Kallunki, Tuula Anneli, 2020, In: Cells. 9, 9, 5 p., 2117.

    Research output: Contribution to journalEditorialResearchpeer-review

  9. Published

    Zinc Finger Transcription Factor MZF1-A Specific Regulator of Cancer Invasion

    Brix, D. M., Clemmensen, K. K. B. & Kallunki, Tuula Anneli, 2020, In: Cells. 9, 18 p., 223.

    Research output: Contribution to journalReviewResearchpeer-review

  10. 2021
  11. Published

    Identification of lysosome‐targeting drugs with anti‐inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancers

    Hansen, M. B., Postol, M., Tvingsholm, S., Nielsen, I. Ø., Dietrich, T. N., Puustinen, P., Maeda, K., Dinant, C., Strauss, R., Egan, D., Jaattela, Marja & Kallunki, Tuula Anneli, 2021, In: Cellular Oncology. 44, p. 805–820

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. 2022
  13. Published

    Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer

    Lima, T. S., De Oliveira Souza, Luciano, Iglesias Gato, Diego, Elversang, J., Jørgensen, Flemming Steen, Kallunki, Tuula Anneli, Røder, Andreas, Brasso, K. & Moreira, José, 2022, In: Frontiers in Pharmacology. 13, 13 p., 869461.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Kinase Inhibitors in the Treatment of Ovarian Cancer: Current State and Future Promises

    Skorda, A., Bay, M. L., Hautaniemi, S., Lahtinen, A. & Kallunki, Tuula Anneli, 2022, In: Cancers. 14, 24, 33 p., 6257.

    Research output: Contribution to journalReviewResearchpeer-review

  15. 2023
  16. Published

    Activation of invasion by oncogenic reprogramming of cholesterol metabolism via increased NPC1 expression and macropinocytosis

    Skorda, A., Lauridsen, A. R., Wu, C., Huang, J., Mrácková, Monika, Winther, N. I., Jank, V., Sztupinszki, Z., Strauss, R., Bilgin, M., Maeda, K., Liu, B., Luo, Y., Jaattela, Marja & Kallunki, Tuula Anneli, 2023, In: Oncogene. 42, p. 2495–2506

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 195069018